Centre Hospitalier Regional Universitaire de Lille has patented new 3C-like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of ...
YouTube on MSN
How long does SARS-CoV-2 last on surfaces? What we know
If a surface is contaminated with the SARS-CoV-2 virus, how long does it pose a risk of infection? Hosted by: Hank Green SciShow has a spinoff podcast! It's called SciShow Tangents. Support SciShow by ...
Six viral diseases — including COVID-19, the flu and norovirus — have been found at high concentrations in Lawrence ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...
The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.
The 2024-2025 COVID-19 vaccines protected against COVID-19-associated ED and urgent care visits among US pediatric patients.
In a multi-institutional study published today in Nature Nanotechnology, researchers from The University of Texas MD Anderson ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...
A rapid interferon response from nasal epithelial cells induces a cascade of responses during infection, from reduced viral ...
A mobile phone application can characterize patterns of recovery from neurological manifestations of post-acute sequelae of severe acute respiratory syndrome co ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
In a new study, researchers at Yale University performed surveillance to understand the current coronaviral landscape of wild and domestic animals in the northeastern United States. They found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results